Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HIV Long Terminal Repeat

Known as: Human Immunodeficiency Virus LTR, Human Immunodeficiency Virus Long Terminal Repeat, Long Terminal Repeat, HIV 
Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and… Expand
National Institutes of Health

Related topics

Related topics

9 relations
Gene Products, nefHIV EnhancerSp1 Transcription Factoraspects of radiation effects
Expand

Narrower (3)

HIV-1 LTRSp1-Binding Site, HIVTrans-Acting Responsive Region, HIV

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat.
The transcription of HIV1 provirus is regulated by both cellular and viral factors. Various evidence suggests that Tat protein… Expand
Highly Cited
1995
Highly Cited
1995
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters.
The four Rep proteins encoded by adeno-associated virus type 2 (AAV-2) inhibit transcription of their own promoters and of… Expand
Highly Cited
1993
Highly Cited
1993
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
Transcription of type 1 human immunodeficiency virus (HIV-1) provirus is governed by the viral long terminal repeat (LTR). Drugs… Expand
Highly Cited
1993
Highly Cited
1993
The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via…
The 86K immediate early (IE) 2 protein of human cytomegalovirus trans-activates a number of homologous and heterologous promoters… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1991
Highly Cited
1991
A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins.
The major immediate-early (IE) promoter of human cytomegalovirus directs the expression of several differentially spliced and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1990
Highly Cited
1990
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Regulation of human immunodeficiency virus (HIV) gene expression is dependent on specific regulatory regions in the long terminal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1989
Highly Cited
1989
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
The tat gene of HIV-1 is a potent trans-activator of gene expression from the HIV long terminal repeat (LTR). To define the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1988
Highly Cited
1988
An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.
Acquired immunodeficiency syndrome patients are frequently coinfected with Epstein-Barr virus (EBV). In this report, we… Expand
Highly Cited
1988
Highly Cited
1988
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
Human immunodeficiency virus 1 has been implicated as the main etiologic agent of the acquired immunodeficiency syndrome. However… Expand
Highly Cited
1986
Highly Cited
1986
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
To investigate whether DNA viruses can augment gene expression of the human immunodeficiency virus (HIV), cotransfection… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE